The Art of Integrated Drug Development and Manufacturing

Integrated development improves speed, quality, and scalability in drug production. This article highlights how ten23 health streamlines the entire process—from molecule characterization to commercial manufacturing—under one roof.

About the Author

Adithya (Adi) Balasubramanian

Imagine ordering a tailored suit or bespoke dress. The quality of the fabric is key, of course, but the true magic lies with the tailor. Their expertise in taking measurements, cutting, and assembling creates something fitted perfectly to you. Even average fabric, in the hands of a skilled tailor, can become something special.

Now, consider this process but break it into three separate shops. One shop measures you, another cuts the fabric, and another assembles it. The result? Miscommunication, inefficiency, and an end product that might not fit well at all.

Alternatively, what if one skilled tailor handles everything from start to finish? With a cohesive vision, careful planning, and expert craftsmanship, they create something flawless. This same principle is why integration is critical in drug development and manufacturing, especially for complex therapeutics like biologics.

At ten23 health, we specialize in providing end-to-end integrated solutions for drug development and manufacturing. By uniting scientific expertise and advanced technology under one roof, we ensure consistency, quality, and efficiency—from concept to product launch.

Designing for Quality and Scalability

Our process starts with a principle that drives everything we do: focusing on manufacturability and usability from the very beginning. Instead of tackling potential issues late in development when they’re costly and time-consuming to fix, we can support to identify and address risks early. This proactive approach leads to a drug product that is not only highly reliable but also scalable from clinical trials to full commercial production.

By considering both patient needs and manufacturing feasibility right from the start, we avoid surprises later and streamline the path from development to production.

Early Biophysical and Molecular Understanding

Every great product is built on a solid foundation. For us, that foundation begins with a detailed analysis of the active ingredient, the molecule or therapeutic modality at a molecular level. Using advanced tools, we study important factors such as colloidal behaviour and thermal stability. These insights guide formulation design,and in combination with the assessment of formulations on stability and against other stress conditions, supports product developability. .

Harmonizing Formulation, Packaging, and Devices

The interplay between a drug formulation, its packaging, and the device that delivers it is complex and critical. When these elements aren’t aligned, the risks can range from inefficiencies in production to delivery challenges for patients.

At ten23 health, we align these components early in development. This includes guiding the choice of the appropriate primary packaging, and subsequently performing assessments for materials and its critical material attributes such as tungsten and silicon oil in pre-filled syringes (PFS). This level of foresight eliminates compatibility (stability and functionality) issues and ensures a seamless transition from development to clinical to commercial use.

Optimizing Delivery through Rheological Insight

Imagine a drug product that’s too viscous to be delivered through a syringe. Beyond the hassle for patients, this could compromise the product’s usability entirely. To prevent such issues, we conduct early rheological and syringeability evaluations. This ensures the drug product flows well, whether in clinical trials or commercial batches, and consistently meets patient needs.

Primary Packaging and Manufacturability Alignment

Choosing the right primary packaging materials (PPM) isn’t as simple as it sounds. From the Quality Target Product Profile (QTPP) to manufacturing feasibility, every detail matters. That’s why we align PPM decisions with manufacturability requirements early on. This avoids costly redesigns or delays down the road, streamlining production efficiency while protecting product integrity.

Critical Manufacturing Parameters

A drug’s final manufacturing process needs to be reliable, reproducible, and robust. This requires attention to every critical parameter, from filling speeds to stopper placement. By focusing on these factors during development, we ensure product consistency and quality in every phase.

Driving Cost Savings and Time Efficiency

Integrated development isn’t just better for quality; it’s better for your budget. Small-scale development takes place earlier and is far cheaper than large-scale GMP manufacturing. Through our integrated approach, we also reduce material waste by relying on small-scale models for early testing.

Time savings are another major benefit. We conduct non-GMP studies early, gaining insights into manufacturability that help us sidestep potential GMP-related delays. The result? A faster process with critical milestones achieved on schedule.

Reducing Risks and Boosting Efficiency

Every step in our integrated approach is designed to minimize the chance of downstream issues. By identifying risks upfront, we deliver robust, production-ready products with fewer surprises during scale-up. Our focus on GMP efficiency ensures that technology transfers are smooth, batch success rates are high, and reworks are rare.

Why Integrated Drug Development and Manufacturing Matter

Fragmented processes, where formulation design, process development, and final manufacturing are disconnected, often lead to inefficiencies, costly delays, and compromised product quality. At ten23 health, we resolve these challenges by integrating all stages of development and manufacturing. Our holistic approach combines state-of-the-art facilities, cutting-edge research, and unparalleled expertise for seamless drug production.

With facilities like ten23 addressing Development, Manufacturing and Testing, we offer a comprehensive suite of services, including Class-A isolators in Class-C environment and meticulous handling of critical details like stopper settings in pre-filled syringes and cartridges. Annex 1 compliance and deep knowledge of processes ensure we deliver exceptional results every time.

The ten23 health Difference

For us, integrated development and manufacturing isn’t just a process; it’s a philosophy. From creating small-scale clinical batches to producing large-scale commercial products, we ensure quality, consistency, and efficiency every step of the way.

At ten23 health, our goal is simple but vital: providing high-quality pharmaceutical drug products that are safe, effective, and reliable for patients worldwide. Integration is what makes it possible. And we’re proud to be leading the way.

Author: Adithya (Adi) Balasubramanian